ClinicalTrials.Veeva

Menu

The Effects Upon the Bladder of Transcutaneous Tibial Nerve Stimulation in Acute Traumatic Spinal Cord Injury

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Completed

Conditions

Neurogenic Bladder
Spinal Cord Injury

Treatments

Device: Transcutaneous Tibial Nerve Stimulation
Device: Control

Study type

Interventional

Funder types

Other

Identifiers

NCT02573402
HSC-MS-15-0806

Details and patient eligibility

About

The purpose of this research study is to evaluate the effects upon the bladder of electric stimulation of the leg's tibial nerve in people with acute spinal cord injury with an intervention called transcutaneous tibial nerve stimulation (TTNS).

Full description

In this study, TTNS will be used to help neurogenic bladder in SCI. First, acute SCI subjects which respond to TTNS will be identified as seen on urodynamic studies (USD). Then, responders will be invited to participate in a randomized control trial of a 2-week protocol of TTNS to test for safety and efficacy during inpatient rehabilitation to evaluate bladder changes based upon pre- and post- urodynamic testing, as well as 2-month follow-up.

Enrollment

19 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Enrollment within 6 weeks of injury
  • Neurologic level rostral to T10 (T9 and above). This is a significant neurologic level because the bladder remains innervated at these levels, without damage to the nerve cell bodies of the bladder within the spinal cord.
  • Location and transportation available for follow-up appointments

Exclusion criteria

  • History of peripheral neuropathy or premorbid symptoms of peripheral neuropathy
  • Known etiologies that may cause peripheral neuropathy (i.e. diabetes mellitus, hypothyroidism, autoimmune diseases, alcoholism, hx of chemotherapy, etc.)
  • History of genitourinary diagnoses (i.e. prostate hypertrophy, overactive bladder, cancer, etc.)
  • Pregnancy
  • History of central nervous system disorder (i.e. prior SCI, stroke, brain injury, Parkinson's disease, MS, etc.)
  • Morbid obesity
  • Ventilator dependent respiration
  • Significant autonomic dysreflexia during baseline urodynamic study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

19 participants in 2 patient groups

Transcutaneous Tibial Nerve Stimulation
Experimental group
Description:
Transcutaneous Tibial Nerve Stimulation (TTNS) applied to subjects for 2-week protocol.
Treatment:
Device: Transcutaneous Tibial Nerve Stimulation
Control
Sham Comparator group
Description:
Sham stimulation.
Treatment:
Device: Control

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems